274 related articles for article (PubMed ID: 16641575)
1. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
Orel R; Brecelj J; Homan M; Heuschkel R
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
[TBL] [Abstract][Full Text] [Related]
2. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
5. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
6. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
[TBL] [Abstract][Full Text] [Related]
7. Bile and acid reflux in the pathogenesis of reflux oesophagitis in children.
Jiang M; Chen J; Chen F; Yu J; Liang J; Zhang Y; Ou B
J Paediatr Child Health; 2009; 45(1-2):64-7. PubMed ID: 19208069
[TBL] [Abstract][Full Text] [Related]
8. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
9. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Todd JA; Basu KK; de Caestecker JS
Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
11. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
[TBL] [Abstract][Full Text] [Related]
12. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
Wittmann T; Rosztóczy A; Fehér A; Jármay K; Oláh T; Szendrényi V; Kiss I
Orv Hetil; 1998 May; 139(18):1077-81. PubMed ID: 9608770
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of gastro-oesophageal reflux disease.
De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
Heyman MB; Zhang W; Huang B; Chiu YL; Amer F; Winter HS
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
[TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
[TBL] [Abstract][Full Text] [Related]
18. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.
Hoffman I; Tertychnyy A; Ectors N; De Greef T; Haesendonck N; Tack J
J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945
[TBL] [Abstract][Full Text] [Related]
19. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
Katz PO
Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]